BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Genprex

Genprex logo

Founded
2009
Geography
United States of America based
Funding
$12.200 M

Genprex is a clinical stage gene therapy company developing molecular therapies to better target lung cancer cells. Their new approach to treating cancer is based upon our novel proprietary technology platform, including our initial product candidate, Oncoprex immunogene therapy, or Oncoprex.

Technologies

Gene Therapy Startups  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet